Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons K.S.M. van der Geest

Publicaties

A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis

Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica:: comparison of disease characteristics and treatment requirement. Reply

Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics

Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Improved Diagnostic Accuracy for Polymyalgia Rheumatica using FDG-PET/CT with Clinical Diagnosis or 2012 ACR/EULAR Classification Criteria

Large vessel giant cell arteritis

Lees meer

Pers/media

Reuma inspiratieavond webinar UMCG

Vasculitis Foundation: international research insights

Vasculitis Stichting: Impact van de COVID-19 pandemie op patiënten met reuscelarteriitis

Alleen paardenmiddel helpt tegen spierreuma

Rheumatology Grant 2017 - De PMR-bursitisstudie

Goede balans tussen aanval en verdediging

Sleutel tot een gezonde levensavond

Lees meer